Robin Smith
Neurology with Special Qualifications in Child Neurology · Garden City, NYNPI 1518037647
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 392 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 13.4% — the pattern of someone who eats at a lot of different presentations.
Across 392 payments — averaging $19.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$1K
- Tris Pharma Inc$914
- Corium, LLC$880
- Ironshore Pharmaceuticals Inc.$812
- UCB, Inc.$716
- Eisai Inc.$522
- plus $3K from 24 others
What the payments were for
- Food & beverage$7,728100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 47 | $1,036 |
| Tris Pharma Inc | 61 | $914 |
| Corium, LLC | 53 | $880 |
| Ironshore Pharmaceuticals Inc. | 47 | $812 |
| UCB, Inc. | 30 | $716 |
| Eisai Inc. | 19 | $522 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $487 |
| Neurelis, Inc. | 20 | $465 |
| Greenwich Biosciences, Inc. | 13 | $307 |
| AbbVie(2 entities) | 15 | $294 |
| Adlon Therapeutics L.p. | 13 | $242 |
| Aquestive Therapeutics, Inc. | 12 | $185 |
| Vertical Pharmaceuticals, LLC | 7 | $135 |
| Neos Therapeutics, LP | 5 | $121 |
| Jazz Pharmaceuticals Inc. | 4 | $108 |
| Teva Pharmaceuticals USA, Inc. | 4 | $66 |
| Azurity Pharmaceuticals, Inc. | 3 | $61 |
| Zogenix Inc. | 2 | $45 |
| Arbor Pharmaceuticals, Inc. | 2 | $42 |
| Upsher-smith Laboratories LLC | 2 | $38 |
| Collegium Pharmaceutical, Inc. | 2 | $35 |
| Avion Pharmaceuticals | 2 | $34 |
| Metacel Pharmaceuticals LLC | 2 | $34 |
| Sunovion Pharmaceuticals Inc. | 2 | $30 |
| PTC Therapeutics, Inc. | 1 | $25 |
| Shire North American Group Inc | 1 | $25 |
| Biocodex, Inc. | 1 | $23 |
| Amneal Pharmaceuticals LLC | 1 | $17 |
| NS Pharma, Inc. | 1 | $14 |
| Cranial Technologies, Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,728 in reported general payments places this provider in the 80th percentile of 161 neurology with special qualifications in child neurology providers in New York.
See all neurology with special qualifications in child neurology providers in New York →
Other neurology with special qualifications in child neurology in Garden City
- Claudia ChiribogaNew York$220K
- Eric SegalN White Plains$133K
- Kaleb YohayNew York$125K
- Heather LauNew York$103K
- Louis ManganasEast Setauket$86K
- Darryl DevivoNew York$67K
- Mary Lynn ChuNew York$66K
- Jonathan MinkRochester$54K
- Sanjeev KothareNew Hyde Park$53K
- Mohammad QasaymehAmherst$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.